Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guiling Chen

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Frontiers in Pharmacology|May 12, 2020
Quercetin Combined With Human Umbilical Cord Mesenchymal Stem Cells Regulated Tumour Necrosis Factor-α/Interferon-γ-Stimulated Peripheral Blood Mononuclear Cells <i>via</i> Activation of Toll-Like Receptor 3 SignallingGuiling Chen, Yang Ye, Ming Cheng, et al.
Cellular and Molecular Neurobiology|August 30, 2018
Curcumin Attenuates gp120-Induced Microglial Inflammation by Inhibiting Autophagy via the PI3K PathwayGuiling Chen, Sisi Liu, Rui Pan, et al.
Chemical Communications (Cambridge, England)|October 29, 2021
Recent advances in radical-based C-F bond activation of polyfluoroarenes and <i>gem</i>-difluoroalkenesJunlei Wang, Han Gao, Chengcheng Shi, et al.
Clinical Therapeutics|September 7, 2018
Pharmacokinetics, Safety, and Tolerability of the Direct-acting Hepatitis C Antiviral Sofosbuvir in HealthyChineseSubjectsXiaojiao Li, Hong Chen, Junqi Niu, et al.
Neuroscience Letters|July 23, 2019
Madecassoside ameliorates lipopolysaccharide-induced neurotoxicity in rats by activating the Nrf2-HO-1 pathwaySisi Liu, Guangming Li, Haijie Tang, et al.
Drug Design, Development and Therapy|June 2, 2026
Phase I, Randomized, Double-Blind, Placebo-Controlled Trial Investigating the Safety, Tolerability, and Pharmacokinetics of BS1801 in Healthy Chinese Adult SubjectsGuiling Chen, Guoping Sheng, Kaiqi Wu, et al.
Cancer Chemotherapy and Pharmacology|July 26, 2018
Tolerance, variability, and pharmacokinetics of bevacizumab biosimilars in Chinese healthy male subjectsHong Zhang, Qingmei Li, Xiaoxue Zhu, et al.
International Journal of Clinical Pharmacology and Therapeutics|January 22, 2019
A phase I, randomized, double-blinded, single-dose study evaluating the pharmacokinetic equivalence of the biosimilar IBI305 and bevacizumab in healthy male subjects
Hong Zhang, Xiaoxue Zhu, Haijing Wei, et al.
International Journal of Clinical Pharmacology and Therapeutics|July 28, 2018
Pharmacokinetics and safety profile of desmopressin oral tablet formulations in healthy Chinese subjects under fasting and fed conditionsXiaojiao Li, Hong Zhang, Xiaoxue Zhu, et al.
Infectious Diseases and Therapy|January 25, 2023
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Anti-C5a Antibody BDB-001 for Severe COVID-19: A Randomized, Double-Blind, Placebo-Controlled Phase 1 Clinical Trial in Healthy Chinese AdultsGuiling Chen, Nan Li, Xiahong Dai, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Frontiers in Pharmacology|May 12, 2020
Quercetin Combined With Human Umbilical Cord Mesenchymal Stem Cells Regulated Tumour Necrosis Factor-α/Interferon-γ-Stimulated Peripheral Blood Mononuclear Cells <i>via</i> Activation of Toll-Like Receptor 3 SignallingGuiling Chen, Yang Ye, Ming Cheng, et al.
Cellular and Molecular Neurobiology|August 30, 2018
Curcumin Attenuates gp120-Induced Microglial Inflammation by Inhibiting Autophagy via the PI3K PathwayGuiling Chen, Sisi Liu, Rui Pan, et al.
Chemical Communications (Cambridge, England)|October 29, 2021
Recent advances in radical-based C-F bond activation of polyfluoroarenes and <i>gem</i>-difluoroalkenesJunlei Wang, Han Gao, Chengcheng Shi, et al.
Clinical Therapeutics|September 7, 2018
Pharmacokinetics, Safety, and Tolerability of the Direct-acting Hepatitis C Antiviral Sofosbuvir in HealthyChineseSubjectsXiaojiao Li, Hong Chen, Junqi Niu, et al.
Neuroscience Letters|July 23, 2019
Madecassoside ameliorates lipopolysaccharide-induced neurotoxicity in rats by activating the Nrf2-HO-1 pathwaySisi Liu, Guangming Li, Haijie Tang, et al.
Drug Design, Development and Therapy|June 2, 2026
Phase I, Randomized, Double-Blind, Placebo-Controlled Trial Investigating the Safety, Tolerability, and Pharmacokinetics of BS1801 in Healthy Chinese Adult SubjectsGuiling Chen, Guoping Sheng, Kaiqi Wu, et al.
Cancer Chemotherapy and Pharmacology|July 26, 2018
Tolerance, variability, and pharmacokinetics of bevacizumab biosimilars in Chinese healthy male subjectsHong Zhang, Qingmei Li, Xiaoxue Zhu, et al.
International Journal of Clinical Pharmacology and Therapeutics|January 22, 2019
A phase I, randomized, double-blinded, single-dose study evaluating the pharmacokinetic equivalence of the biosimilar IBI305 and bevacizumab in healthy male subjects
Hong Zhang, Xiaoxue Zhu, Haijing Wei, et al.
International Journal of Clinical Pharmacology and Therapeutics|July 28, 2018
Pharmacokinetics and safety profile of desmopressin oral tablet formulations in healthy Chinese subjects under fasting and fed conditionsXiaojiao Li, Hong Zhang, Xiaoxue Zhu, et al.
Infectious Diseases and Therapy|January 25, 2023
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Anti-C5a Antibody BDB-001 for Severe COVID-19: A Randomized, Double-Blind, Placebo-Controlled Phase 1 Clinical Trial in Healthy Chinese AdultsGuiling Chen, Nan Li, Xiahong Dai, et al.
Pageof 4